Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

IMPORTANCE: Hyperprogressive disease (HPD) is a recognized pattern of rapid tumor progression during immune checkpoint inhibitor (ICI) treatment. Definitions of HPD have not been standardized, posing the risk of capturing different tumoral behaviors. OBJECTIVES: To provide a systematic summary of de...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyo Jung, Kim, Kyung Won, Won, Sang Eun, Yoon, Shinkyo, Chae, Young Kwang, Tirumani, Sree Harsha, Ramaiya, Nikhil H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991969/
https://www.ncbi.nlm.nih.gov/pubmed/33760090
http://dx.doi.org/10.1001/jamanetworkopen.2021.1136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991969/
https://www.ncbi.nlm.nih.gov/pubmed/33760090
http://dx.doi.org/10.1001/jamanetworkopen.2021.1136

Ejemplares similares